Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Anwer, Faiz  [Clear All Filters]
2015
Nadeau M, George L, Yeager AM, Anwer F, McBride A. Plerixafor as a salvage mobilization strategy for haploidentical peripheral blood allogeneic stem cell transplantation. Clin Case Rep. 2015;3(9):728-30.
2016
Yun S, Vincelette ND, Abraham I, Puvvada S, Anwer F. Outcome Comparison of Allogeneic versus Autologous Stem Cell Transplantation in Transformed Low-Grade Lymphoid Malignancies: A Systematic Review and Pooled Analysis of Comparative Studies. Acta Haematol. 2016;136(4):244-255.
2018
Ijaz A, Khan AYounas, Malik SUllah, Faridi W, Fraz MAsad, Usman M, Tariq MJunaid, Durer S, Durer C, Russ A, et al. Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors Before and After Allogeneic transplantation. Biol Blood Marrow Transplant. 2018.
2019
Chaudhry QUn Nisa, Iftikhar R, Satti TMehmood, Mahmood SKamran, Ghafoor T, Shamshad GUmair, Shahbaz N, Khan MAli, Khattak TAzam, Rehman J, et al. Outcome of Fludarabine Based Conditioning in High Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single Center Study from Pakistan. Biol Blood Marrow Transplant. 2019.
Warraich Z, Tenneti P, Thai T, Hubben A, Amin H, McBride A, Warraich S, Hannan A, Warraich F, Majhail N, et al. Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Ph+ ALL, A Systematic Review. Biol Blood Marrow Transplant. 2019.
Majeed A, Harris Z, Brucks E, Hinchman A, Farooqui AAli, Tariq MJunaid, Tamizhmani K, Bin Riaz I, McBride A, Latif A, et al. Revisiting role of vaccinations in donors, transplant recipients, immunocompromised hosts, travelers and household contacts of stem cell transplant recipients. Biol Blood Marrow Transplant. 2019.
2020
Iftikhar R, Chaudhry QUn Nisa, Mahmood SKamran, Ghafoor T, Satti HShafique, Shahbaz N, Khan MAli, Khattak TAzam, Shamshad GUmair, Rehman J, et al. Single agent Cyclosporine for Graft versus host disease prophylaxis in patients with acquired Aplastic Anemia receiving fludarabine based conditioning. Biol Blood Marrow Transplant. 2020.
Hong S, Rybicki L, Corrigan D, Hamilton BK, Sobecks R, Kalaycio M, Gerds AT, Dean R, Hill B, Pohlman B, et al. Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era. Hematol Oncol Stem Cell Ther. 2020.
2021
Hassan H, Anwer F, Javaid A, Hashmi H. Progress in Research: Daratumumab Improves Treatment Outcomes of Patients with AL Amyloidosis. Crit Rev Oncol Hematol. 2021:103435.
2022
Maqbool S, Nadeem M, Shahroz A, Naimat K, Khan I, Tahir H, Rehman A, Anwer F, Iftikhar R, Lee KYiu. Engraftment syndrome following Hematopoietic stem cell transplantation: a systematic approach toward diagnosis and management. Med Oncol. 2022;40(1):36.
Chakraborty R, Siddiqi R, Wilson G, Gupta S, Asghar N, Husnain M, Aljama M, Behera TRanjan, Anwer F, Perrot A, et al. Impact of autologous transplantation on survival in patients with newly diagnosed multiple myeloma who have high-risk cytogenetics: A meta-analysis of randomized controlled trials. Cancer. 2022.
2023
Mahadevia H, Ponvilawan B, Sharma P, Al-Obaidi A, Qasim H, Koyi J, Anwer F, Raza S. Advancements and future trends of immunotherapy in light-chain amyloidosis. Crit Rev Oncol Hematol. 2023:103917.
Aleixo GFP, Wei W, Chen P-H, Gandhi NS, Anwer F, Dean R, Hamilton BK, Hill BT, Jagadeesh D, Khouri J, et al. The association of body composition and outcomes following autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma. Bone Marrow Transplant. 2023.
Rehman MEbad Ur, Chattaraj A, Mahboob A, Ijaz Z, Franco D, Farhan M, Dharma K, Mumtaz H, Saeed S, Basit J, et al. Total Body Irradiation Versus Chemotherapy Conditioning in Pediatric Acute Lymphoblastic Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis. Clin Lymphoma Myeloma Leuk. 2023.
2024
Gagelmann N, Dima D, Merz M, Hashmi H, Ahmed N, Tovar N, Oliver-Caldes A, Stölzel F, Rathje K, Fischer L, et al. Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma. J Clin Oncol. 2024:JCO2302232.
Gasoyan H, Anwer F, Casacchia NJ, Kovach JD, Valent J, Wang M, Halpern MT, Rothberg MB. Role of Patient Characteristics and Insurance Type in Newly Diagnosed Multiple Myeloma Care Disparities. JCO Oncol Pract. 2024:OP2300672.